middle.news
Microba Reports FY26 Results with Revenue Down 5.8% and Core Testing Revenue Up 92%
12:34pm on Monday 31st of August, 2026 AEST
•
Healthcare
Read Story
Microba Reports FY26 Results with Revenue Down 5.8% and Core Testing Revenue Up 92%
12:34pm on Monday 31st of August, 2026 AEST
Key Points
Total revenue declined 5.8% to $14.76 million
Statutory net loss increased 38.7% to $20.7 million
Core testing revenue surged 92% to $8.6 million
Raised $13 million in equity, strengthening cash position
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Microba Life Sciences (ASX:MAP)
OPEN ARTICLE